[Retracted] Comparison of the Ameliorating Effects of Valsartan and Amlodipine on Vascular Endothelial Dysfunction and Oxidative Stress in Elderly Patients with Type H Hypertension

Table 1

Comparison of general clinical data of the two groups of patients.

Index	Valsartan group (n = 40)	Amlodipine group (n = 42)	t/χ ^2	value
Old (year, x̅ ± s)	70.78 ± 7.05	69.88 ± 6.92	0.583	0.561
Female (n, %)	25 (62.5)	25 (59.52)	0.076	0.782
Smoking history (n, %)	14 (35.0)	11 (26.19)	0.750	0.386
History of alcohol intake (n, %)	7 (17.5)	9 (21.43)	0.201	0.654
BMI (kg/m^2, x̅ ± s)	24.85 ± 3.17	24.69 ± 2.80	0.242	0.809
Average disease duration (year, %)	5.94 ± 2.28	5.76 ± 2.31	0.355	0.724
Average SBP (mmHg, x̅ ± s)	165.85 ± 18.86	169.98 ± 16.12	1.068	0.289
Average DBP (mmHg, x̅ ± s)	91.53 ± 14.55	94.71 ± 14.06	1.006	0..317
Hypertension classification (n, %)
Grade I	25 (62.5)	21 (50.0)	0.254	1.300
Grade II	9 (22.5)	12 (28.57)	0.529	0.396
Grade III	6 (15.0)	9 (21.43)	0.452	0.567
Laboratory metrics (x̅ ± s)
TC (mmol/L)	4.49 ± 1.21	4.62 ± 1.08	0.514	0.608
TG (mmol/L)	1.46 ± 0.40	1.54 ± 0.39	0.917	0.362
LDL-C (mmol/L)	2.84 ± 0.93	2.71 ± 0.77	0.691	0.492
HDL-C (mmol/L)	1.02 ± 0.20	1.07 ± 0.26	0.973	0.334
Plasma Hcy (µmol/L)	18.10 ± 5.85	19.15 ± 6.90	0.742	0.461
FBP (mmol/L)	4.94 ± 2.31	5.01 ± 2.48	0.132	0.895

DBP, diastolic blood pressure; SBP, systolic blood pressure; TC, total cholesterol; TG, triglyceride; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; Hcy, homocysteine; FBP, fasting blood glucose.